Press releases
You will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists.
Nucala is approved in Canada for use in adolescents and children aged 6 years and above with severe eosinophilic asthma
Bora Pharmaceuticals to Acquire GSK Mississauga-based Facility
Read more - Bora Pharmaceuticals to Acquire GSK Mississauga-based Facility Read more
CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
ZEJULA – a new maintenance treatment option for Canadians living with ovarian cancer – now available in Canada
GSK named one of Canada’s Top 100 Employers
Read more - GSK named one of Canada’s Top 100 Employers Read more
GSK Partners with Save the Children to Address Mental Health Concerns of Children Affected by Cat Lake Crisis in Northern Ontario
Two new options for self-administration of NUCALA now approved in Canada, making it the first anti-IL5 biologic to offer patients with severe eosinophilic asthma a choice of how and where to receive treatment
Many Canadian Adults Acknowledge the Importance of Immunization Yet Are Not Getting Vaccinated
Local employee selected for charity mountain climb
Read more - Local employee selected for charity mountain climb Read more